Opportunistic infections after long-term treatment with azathioprine (AZA) have not been noted in patients with myasthenia gravis (MG). We report on a 56-year-old woman with generalized MG who presented with cytomegalovirus infection after being treated with AZA for 17 years. The indication for immunosuppressive treatment in MG should be regularly reconfirmed, particularly since at least 50% of patients can discontinue AZA after two to four years without risk of exacerbation
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine recep...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Introduction: Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompas...
Summary: Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunc...
The long-term risk of malignancies in patients treated with immunosuppressive drugs is a concern amo...
In chronic autoimmune conditions such as myasthenia gravis (MG), immunosuppression-usually long-term...
Late-onset myasthenia gravis (LOMG) is a unique MG subgroup. More information is needed on its subgr...
Myasthenia gravis (MG) is an autoimmune disorder characterized by autoantibodies against acetylcholi...
BACKGROUND:Long-term immunosuppression is often required in myasthenia gravis (MG). There are no pub...
Earlier diagnosis and the availability of effective treatments have reduced the burden of high morta...
<p>The patient was a 26-year-old woman with a 6-year history of myasthenia gravis. She did not toler...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
One hundred consecutive patients with myasthenia gravis (MG) referred between 1985 and 1989 were ana...
Introduction Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular junction. Therapy fo...
ObjectiveTo determine whether discontinuation or marked reduction of mycophenolate mofetil (MMF) in ...
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine recep...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Introduction: Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompas...
Summary: Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunc...
The long-term risk of malignancies in patients treated with immunosuppressive drugs is a concern amo...
In chronic autoimmune conditions such as myasthenia gravis (MG), immunosuppression-usually long-term...
Late-onset myasthenia gravis (LOMG) is a unique MG subgroup. More information is needed on its subgr...
Myasthenia gravis (MG) is an autoimmune disorder characterized by autoantibodies against acetylcholi...
BACKGROUND:Long-term immunosuppression is often required in myasthenia gravis (MG). There are no pub...
Earlier diagnosis and the availability of effective treatments have reduced the burden of high morta...
<p>The patient was a 26-year-old woman with a 6-year history of myasthenia gravis. She did not toler...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
One hundred consecutive patients with myasthenia gravis (MG) referred between 1985 and 1989 were ana...
Introduction Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular junction. Therapy fo...
ObjectiveTo determine whether discontinuation or marked reduction of mycophenolate mofetil (MMF) in ...
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine recep...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Introduction: Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompas...